0.10Open0.10Pre Close0 Volume4 Open Interest0.50Strike Price0.00Turnover0.00%IV-426.32%PremiumNov 15, 2024Expiry Date0.42Intrinsic Value100Multiplier7DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma0.76Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Bright Green Stock Discussion
Bright Green Corporation, a key player in the cultivation and supply of plant-based materials, has announced a strategic partnership with Benuvia Pharmaceuticals. This partnership signifies a major step in the integration of advanced plant-based pharmaceuticals into mainstream medicinal applications. The collabo...
Bright Green Corporation (Nasdaq: BGXX), a company involved in the production, market, and distribution of Schedule I-V plant-based drugs, including opium and cannabis, recently made significant strides in securing financial resources to advance its commercialization efforts. The company has announced the acquisition of a $3.5 million funding commitment under an ex...
No comment yet